Collegium Pharmaceutical, Inc. (COLL) — Stock Score Summary

Collegium Pharmaceutical, Inc. (COLL) has a MoatMap StockRank of 92/100 based on Quality (69/100), Value (63/100), and Momentum (46/100) factor scores. The current signal is STRONG BUY. Specialty pharmaceutical company focused on pain management. It lacks the structural growth drivers of the CDMO cycle or other core themes.

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company focused on developing and commercializing tamper-deterrent, abuse-deterrent formulations of pain medications. Leveraging its proprietary DETERx® technology, the company addresses the critical public health need for safer opioid analgesics. Collegium holds a niche market position by combining pain management with abuse-deterrent technology.

Key Financial Metrics

Price$31.06
Market Cap$1.1B
P/E (TTM)15.87
P/E (Forward)4.29
Price/Book3.39
Return on Equity27.4%
Return on Invested Capital14.4%
Debt/Equity297.57
Gross Margin89.2%
Operating Margin16.0%
Revenue Growth8.9%
Free Cash Flow$333M

Collegium Pharmaceutical, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Collegium Pharmaceutical, Inc.’s (COLL) StockRank?
MoatMap’s StockRank for Collegium Pharmaceutical, Inc. (COLL) is 92/100, with a Strong Buy signal. It is a composite of Quality (69), Value (63), and Momentum (46) factor ranks across MoatMap’s 19,000+ stock universe.
Does Collegium Pharmaceutical, Inc. have an economic moat?
Collegium Pharmaceutical, Inc. (COLL) has a Quality factor score of 69/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Collegium Pharmaceutical, Inc. a buy, hold, or sell?
MoatMap’s current signal for Collegium Pharmaceutical, Inc. (COLL) is Strong Buy, based on a StockRank of 92/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Collegium Pharmaceutical, Inc. in?
Collegium Pharmaceutical, Inc. (COLL) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).
Browse all ranked stocksCOLL deep dive reportAI ChampionsHow we score stocksSense-check another stock